Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02318550 · ClinicalTrials.gov registry record
Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD
A clinical trial, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- 262
- Enrollment target
NCT02318550: Completed study, sponsored by Lancaster General Hospital.
NCT02318550 is a clinical trial that has completed, run by Lancaster General Hospital. The registered enrollment target is 262 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02318550 has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
Study Summary
The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.
Interventions
- OTHER MRI Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-06-30 |
What the finished NCT02318550 record still lists
NCT02318550 is an observational study that tracks outcomes without assigning an intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI Scan is the first listed.
NCT02318550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02318550 about?
NCT02318550 is a clinical study titled "Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD". The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.
What is the current status of trial NCT02318550?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2014-12. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT02318550?
The interventions under investigation include: MRI Scan (OTHER).
Who is sponsoring clinical trial NCT02318550?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia